Nelkarmi approved in the US for previously-treated advanced ALK-positive non-small cell lung cancer 17 November
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine 03 November
Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD's The Liver Meeting 2026 02 November